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Abstract Mesenchymal stromal cells (MSC) have been
introduced into the Weld of tissue-engineered airway trans-
plantation. Since patients with extensive tracheal defects
often require an open tracheotomy, this study investigated
if MSC could be obtained from the adipose tissue of the
neck during this procedure. Cells were isolated by plastic
adherence from the adipose tissue of 8 patients. Cell iso-
lates were analyzed for (i) proliferation, (ii) the expression
of CD marker molecules and (iii) multilineage diVerentia-
tion. The isolated spindle-shaped cells showed a high
proliferation capacity and the Xow cytometric analysis
revealed a distinct population meeting the criteria for MSC.
Using classical MSC cultivation protocols the characterized
cells showed adipogenic, chondrogenic and osteogenic
diVerentiation for all analyzed cell isolates. This study was
able to demonstrate that suYcient amounts of stem/progen-
itor cells can be easily isolated from adipose tissue of the
neck obtained during open tracheotomy. These cells may be
a source for future tracheal replacement therapies.
Keywords Mesenchymal stem cells · Mesenchymal 
stromal cells · MSC · Tissue engineering · Tracheal 
transplantation · Adipose tissue · Tracheotomy
Introduction
Airway stenosis can lead to atelectasis and severe obstruc-
tive pneumonia. To secure airway function tracheotomy is
often necessary. Moreover, tracheomalacia due to trauma,
severe inXammation or malignant diseases may require
extensive surgical treatment. Various therapeutic
approaches for stenosis and obstruction of the trachea or
bronchi have been reported, including bronchoscopic dila-
tation, laser ablation, airway stenting and surgical broncho-
plasty [1, 2]. The current gold standard in surgical
treatment of severe stenosis or defects is resection with
end-to-end anastomosis. However, large airway defects
(>5 cm) still present a major problem for clinicians because
of the absence of eVective methods of treatment. Recent
studies have focused on the replacement of the cervical tra-
chea or main bronchi based on the concept of in situ-tissue
engineering [3, 4]. Attempts to provide synthetic grafts for
application in humans have been associated with poor epi-
thelization, exposure of the prosthesis matrix and poor
functional outcome [5, 6]. Allograft transplants such as
aorta, functioning as a biologic incubator, may allow host
cells to migrate into the airway transplant in vivo [7]. In
particular, after malignant or infectious diseases lifelong
immunosuppressive medication is contraindicated, but it is
necessary to avoid rejection of allogenic material. This
restricts the clinical application of allografts. Therefore,
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gies. Autologous bone marrow mesenchymal stem cells
have recently been introduced into the Weld of tissue-
engineered airway transplantation. Besides autologous
epithelial cells and chondrocytes, bone marrow-derived
mesenchymal stem cells were used for the complete
replacement of the left bronchus in a bioengineered human
trachea [8]. Bone marrow mesenchymal stem cells have
been found to diVerentiate along multiple mesenchymal lin-
eages [9–11]. Even though it is commonly accepted that
multipotent mesenchymal stem cells exist, there is clear
evidence that isolation via plastic adherence results in het-
erogeneous populations including subsets of stem/progeni-
tor cells with a contingently diVerent stem cell potential. To
point out this heterogeneity multipotent Wbroblast colony-
forming cells have been reclassiWed as mesenchymal stro-
mal cells (MSC) [11]. Besides bone marrow, other sources
of adult stem cells have been characterized, posting the
hypothesis that stem cells capable of multilineage diVeren-
tiation might reside in any post natal-organ [12]. Adipose-
derived MSC possess a particular relevance for tissue engi-
neering settings because these cells can be harvested and
handled easily and eVectively without donor site morbidity.
In rats regeneration of the trachea using a bioengineered
scaVold with adipose-derived MSC has already been
reported [13].
This study investigated whether adult MSC can be
retrieved during a tracheotomy from the adipose tissue of
the neck. The cells were isolated from the adipose biopsies
and characterized by their adherence to plastic culture
dishes, their Wbroblastoid morphology, their ability to pro-
liferate in culture and by means of Xow cytometric analysis.
The stem/progenitor cell isolates showed characteristics of
multipotent adult stem cells, and given the appropriate cul-
ture conditions, demonstrated multilineage diVerentiation
into adipogenic, osteogenic and chondrogenic cells. Fur-
thermore, there is strong evidence that these adipose tissue-
derived cells meet the requirements for MSC [11] and may
therefore be applicable for clinical tissue-engineered air-
way transplantation in the future.
Materials and methods
Isolation of human stem/progenitor cells
The isolation of human stem/progenitor cells from the adi-
pose tissue surrounding the trachea was carried out with
samples of eight patients, aged between 55 and 78 years, in
accordance with the patients` informed consent (approval
by the ethics committee, University of Lübeck, no. 05-218)
and given indication for surgical tracheotomy. The biopsy
was removed during the classic procedure of an open
tracheotomy which was performed under general anesthe-
sia in the operating room of the intensive care unit. Approx-
imately 2–3 g of adipose tissue were removed from the
neck as a routine procedure and immediately transferred to
the laboratory for further processing. Adipose tissue sam-
ples were digested with basal medium supplemented with
1 mg/ml collagenase A (Sigma, München, Germany) for
45 min at 37°C, sieved, centrifuged, and washed with basal
medium. The number of cells was determined and the cell
suspension was plated onto 75 cm2 tissue culture Xasks
(TPP, Trasadingen, Switzerland). The number of cells
obtained directly after isolation was around 4 £ 105 cells.
Non adherent cells were removed by the Wrst medium
change after 2 days. Single colonies of adherent Wbroblast-
like cells were Wrst visible after 72 h of cultivation. All cul-
tivations were performed at 37°C and 5% CO2.
Cultivation of human stem/progenitor cells
Stem/progenitor cells were cultured in basal medium con-
sisting of Dulbecco’s modiWed Eagle’s medium (DMEM,
Invitrogen, Paisley, U.K.) supplemented with 1% sodium
pyruvate (PAA, Pasching, Austria), 1% L-glutamine (PAA,
Pasching, Austria), 1% MEM non-essential amino acids
(Invitrogen, Paisley, U.K.), 1% penicillin/streptomycin
(PAA, Pasching, Austria) and 10% fetal bovine serum
(PAA, Pasching, Austria). When adherent cells reached
approximately 80–90% conXuence, they were washed with
phosphate-buVered saline (PBS), trypsinized and centri-
fuged for 5 min at 250g. The cells were plated at a density
of 1 £ 104 cells/cm2 and passaged every 4–10 days. When
reaching subconXuence, the cells were phenotyped using
Xow cytometric analysis (passage p4) or replated for diVer-
entiation. Passages used for diVerentiation in three indepen-
dent samples per experimental group (n = 3) were p4, p6
and p8 in all stem/progenitor cell isolates. The daily dou-
bling index was used to determine the proliferation and
growth properties of the human stem/progenitor cells.
Flowcytometric analysis of human stem/progenitor cells
Trypsin/EDTA-(0.25%) treated cells (4th passage) were
washed twice with FACS buVer (PBS, 1% BSA and 0.1%
NaN3), adjusted to approximately 5 £ 105 cells/ml and sub-
sequently stained. A 100-l cell suspension was incubated
with either 10 l phycoerythrin (PE)-conjugated monoclo-
nal antibodies (mAbs) or 10 l non-conjugated mAbs and a
secondary goat anti-mouse IgG1-PE at 4°C for 30 min. To
discriminate human stem/progenitor cells from cells of
hematopoietic origin, isolates were stained for CD34 and
CD45. In addition, the following antigens were included
into the phenotyping proWle: CD29, CD44, CD54, CD73,
CD105, CD106, CD140b and CD166. Prior to the Xow123
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volume of 500 l with FACS buVer. Cells were analyzed
on a Cytomics FC 500 Xow cytometer using cytomics CXP
software (Beckman Coulter, Krefeld, Germany). At least
10,000 events were acquired and analyzed using a one-
parametric protocol (FL2) and FSC/SSC dot plot diagram
to exclude cell debris by gating. Non-speciWc isotype-
matched controls were used to determine background Xuo-
rescence. All mAbs against the human antigens CD34,
CD45, CD29, CD44, CD54, CD73, CD105, CD106,
CD140b and CD166 were purchased from Becton–Dickinson
(Heidelberg, Germany).
DiVerentiation of human stem/progenitor cells
All diVerentiation assays have been carried out with three
independent samples per experimental group (n = 3). Chon-
drogenic diVerentiation was performed using micro mass
body (MMB) cultivation [14]. Cells were trypsinized,
counted and basal medium was replaced by chondrogenic
induction medium. Aliquots of 2 £ 105 cells in 0.5 ml
chondrogenic induction medium were centrifuged at 65g in
15 ml polypropylene conical tubes. Chondrogenic induc-
tion medium consisted of basal medium supplemented with
0.1 M dexamethasone (Merk, Darmstadt, Germany),
300 M ascorbic acid (Sigma, München, Germany), 1 mM
L-proline (Sigma, München, Germany), 10 ng/ml trans-
forming growth factor (TGF) 3, (R&D, Wiesbaden, Ger-
many) and 1% ITS premix (Becton–Dickinson, Heidelberg,
Germany: 6.25 g/ml insulin; 6.25 g/ml transferrin;
6.25 g/ml selenious acid; 1.25 mg/ml bovine serum albu-
min; 5.35 mg/ml linoleic acid). Samples of MMBs were
taken for RNA-isolation (4 MMB per experimental time
point per sample per day), histochemical or immunhisto-
chemical analysis (1 MMB per sample per day) during the
course of chondrogenic diVerentiation. MMBs prepared for
histochemical and immunhisto-chemical staining were
embedded in Tissue-Tek O.C.T. (Sakura Finetechnical,
Tokyo, Japan), frozen at ¡80°C and cryosectioned (10 m)
for further analysis. To screen for proteoglycan deposits or
marker protein expression within the chondrogenic MMBs,
cryosections were Wxed and stained with Alcian blue or
immunostained. Uninduced MMBs were stained as nega-
tive controls.
To analyze adipogenic and osteogenic diVerentiation,
isolated stem/progenitor cells were diVerentiated via mono-
layer protocols [10, 15]. Adipogenic and osteogenic induc-
tion of the stem/progenitor cells was performed at 80–90%
conXuence. To induce osteogenic diVerentiation cells were
treated with osteogenic medium for 25 days. Osteogenic
medium consisted of basal medium supplemented with
0.1 M dexamethasone (Merk, Darmstadt, Germany),
10 mM -glycerolphosphate (Sigma, München, Germany)
and 300 M ascorbic acid (Sigma, München, Germany). To
induce adipogenic diVerentiation cells were treated with
adipogenic induction medium and adipogenic maintenance
medium for 25 days. Induction medium consisted of basal
medium supplemented with 0.5 mM 3-isobutyl-1-methyl-
xanthine (IBMX Sigma, München, Germany), 1 M dexa-
methasone (Merk, Darmstadt, Germany), 200 M
indomethacin (Sigma, München, Germany) and 2 M insu-
lin (Sigma, München, Germany). Following a four-day
induction period, the adipogenic induction medium was
replaced with adipogenic maintenance medium consisting
of basal medium supplemented with 2 M insulin for
3 days. This cycle was repeated three times and ultimately
followed by a four-day period of adipogenic maintenance
culture.
Lipid accumulation during adipogenic diVerentiation
was demonstrated by Sudan III staining. Cells were washed
with PBS followed by staining with a 0.2% solution of
Sudan III (Sigma, München, Germany) in 70% ethanol.
Alkaline Phosphatase (AP) activity of stem/progenitor cells
diVerentiating along the osteogenic lineage was demon-
strated using the AP staining kit (Sigma, München,
Germany).
Quantitative analysis of histochemical staining
To analyze the diVerentiation of human adipose tissue-
derived stem/progenitor cells from the neck by AP or
Sudan III staining, ten areas of 0.77 mm2 for osteogenic
diVerentiation and ten areas of 0.235 mm2 for adipogenic
diVerentiation were quantiWed per sample per day. The
stained areas were measured in relation to the total area of
cells using ImageJ software (NIH, Bethesda, MD, USA)
and quantiWed in percent. Chondrogenic diVerentiation was
analyzed by measuring Alcian blue-positive stained areas
in relation to the total area of the sectioned MMB using
ImageJ software (NIH, Bethesda, MD, USA) and quantiWed
in percent.
Fluorescent immunostaining
Human stem/progenitor cells cultured on chamber slides or
MMB cryosections were rinsed three times with PBS, Wxed
for 5 min with pre-cooled (¡20°C) methanol-acetone at
4°C, washed four times with PBS and incubated at room
temperature for 30 min with 7.5% bovine serum albumin.
Specimens were then incubated for 1 h with a primary anti-
body in a humidiWed chamber at 37°C. Antibodies speciWc
for the following proteins were used (designation, dilution
ratio in PBS as well as references are given in parentheses):
stromal cell surface marker (STRO-1; 1:50; [16]), collagen
type II (II–II-6B3; 1:20; [17]), collagen type X (XAC9;
1:20; [18]), osteopontin (MPIIIB101; 1:20; [19]), bone123
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ies were obtained from the Developmental Studies Hybrid-
oma Bank (University of Iowa, Iowa City, IA, USA). After
rinsing four times with PBS, slides were incubated for 1 h
at 37°C with either Xuorescein isothiocyanate (FITC, Dia-
nova, Hamburg, Germany; 1:200) or cyanine3 (Cy3, Dia-
nova, Hamburg, Germany; 1:600) labeled anti-mouse IgG
as well as 4,6-Diamidino-2-phenylindole dihydrochloride
(DAPI; Sigma, Taufkirchen, Germany). Slides were
washed four times in PBS and brieXy washed in distilled
water. After immunostaining the specimens were embed-
ded in Vectashield mounting medium (Vector, Burlingame,
CA, USA) and analyzed with the Xuorescence microscope
Axioskop (ZEISS, Oberkochen, Germany). Negative con-
trols were performed using the secondary antibody only.
RT-PCR analysis
Stem/progenitor cells diVerentiated via monolayer or MMB
were collected at diVerent time points, washed twice with
PBS and total RNA was isolated using a standardized RNA
Isolation Kit (Macherey & Nagel, Düren, Germany). The
RNA concentrations were determined by measuring the
absorbance at 260 and 280 nm. Samples of 500 ng RNA
were reverse transcribed using oligo-dT primer and Super-
script II reverse transcriptase following the manufacturer’s
recommendations (Invitrogen, Paisley, U.K.). Aliquots of
1 l from the reverse transcriptase reactions were used for
ampliWcation of transcripts using primers speciWc for the ana-
lyzed genes and Taq polymerase according to the manufac-
turer’s instructions (Fermentas, St. Leon, Germany). Reverse
transcriptase reactions were denatured for 2 min at 95°C, fol-
lowed by ampliWcation for 30–40 cycles of 40 s denaturation
at 95°C, 40 s annealing at the primer-speciWc temperature
and 50 s elongation at 72°C. Primers speciWc for the follow-
ing genes were used (sequence, annealing temperature as
well as size are given in parentheses): PPAR (5- AAA CTC
TGG GAG ATT CTC CT -3, 5- TCT TGT GAA TGG AAT
GTC TT -3, 56°C, 247 bp) [20], aP2 (5- GCT TTG CCA
CCA GGA AAG TG -3, 5- ATG ACG CAT TCC ACC
ACC AG -3, 60°C, 279 bp) [20], C/EBPalpha (5- AGA
AAG GGG TGG AAA CAT AGG -3, 5- GAA AGC
TGA GGG CAA AGG -3, 58°C, 685 bp) [20], osteopontin
(5- ACT GAT TTT CCC ACG GAC CT -3,  5- CAT
TCA ACT CCT CGC TTT CC -3, 58°C, 199 bp), osteocal-
cin (5- CTC ACA CTC CTC GCC CTA TT -3, 5- CGC
CTG GGT CTC TTC ACT AC -3, 58°C, 143 bp), collagen
type II (5- AGG CTC CCA GAA CAT CAC CT -3,
5- ACA GTC TTG CCC CAC TTA CC -3 55°C,
472 bp) [21], Aggrecan (5- GCA GAG ACG CAT CTA
GAA ATT G -3, 5- GGT AAT TGC AGG GAA CAT
CAT T -3, 55°C, 504 bp) [21] and GAPDH (5- CCG CAT
CTT CTT TTG CGT CGC -3, 5- GCA ACT GTG AGG
AGG GGA GAT TCA G -3, 55°C, 1100 bp). Electrophoretic
separation of PCR products was carried out on 2% aga-
rose gels [2% (w/v) agarose (Roth, Karlsruhe, Germany)],
0.7 ng/ml ethidium bromide (Roth, Karlsruhe, Germany).
The fragments were analyzed by computer-assisted densi-
tometry in relation to GAPDH gene expression. The densito-
metric values of each marker were calculated in relation to
GAPDH. From these values the highest of each marker was
taken as 100%. Distilled water and no-RT reactions were
always included as a negative control.
Statistical analysis
Statistical analysis was performed using SigmaPlot 2000
software (Systat, Erkrath, Germany) and calculated accord-
ing to the student’s t test. Samples were analyzed at least in
three independent experiments (n = 3).
Results
Successful establishment of stem/progenitor cells 
after tracheotomy
During an open tracheotomy stem/progenitor cells were iso-
lated from subcutaneous adipose tissue of eight patients, aged
between 55 and 78 years. Plastic adherent cell populations
from adipose tissue of the neck exhibited a typical spindle-
shaped morphology (Fig. 1a). The Wrst colonies of Wbroblast-
like cells could be observed after 72 h, with a 100% successful
rate of stem/progenitor cell isolation. All cell isolates displayed
stable growth characteristics, and STRO-1 could be detected in
all isolates (Fig. 1b). Optimizing cell culture, an optimal cell
growth and maintenance was achieved using a plating density
of 1 £ 104 cells per cm2. During further passages, a daily dou-
bling index of 2.02 was determined (Fig. 1c). The cells did not
diVerentiate spontaneously during culture expansion into any
morphologically identiWable cell type.
Immunophenotypic characterization of stem/progenitor 
cells isolated from tracheotomy
To characterize the isolated stem/progenitor cell popula-
tion, CD surface antigen marker expression was analyzed
by means of Xow cytometric measurement (Fig. 2). The
isolated cells showed a distinct phenotypic population
(>90% homogeneous in passage 4). The stem/progenitor
cell isolates were negative for CD45 (leukocyte common
antigen) and CD34 (gp105-120), indicating that they were
not of hematopoietic origin. The cells expressed CD29 (b1
integrin), CD54 (intercellular adhesion molecule-1) and
CD140b (b platelet-derived growth factor receptor). Analy-
sis for the hyaluronate receptor (CD44), ecto-5-nucleotidase123
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Thy-1) revealed strong expression. The matrix receptor
CD105 (endoglin, SH2), the adhesion molecule CD166
(activated leukocyte cell adhesion molecule) and CD13
(aminopeptidase-N) were found to be expressed. The cells
did not display an expression of CD106 (vascular cell adhe-
sion molecule-1).
Multilineage diVerentiation of tracheotomy-derived 
stem/progenitor cells
During multilineage diVerentiation and characterization of
adipose tissue-derived cell cultures, the isolates were
regularly analyzed by histochemical and immunoXuores-
cence staining for adipogenic, osteogenic and chondrogenic
cell types. RT-PCR analysis conWrmed the multilineage
diVerentiation of the isolated human stem/progenitor cells.
We found that the amount of diVerentiated cells increased
up to almost 70–90% after 25 days of cultivation in line-
age-speciWc induction medium.
Adipogenic diVerentiation
To analyze the adipogenic diVerentiation, the stem/progeni-
tor cells were induced in the expanded monolayer cultures
by treatment with IBMX, dexamethasone, insulin and indo-
methacin. Morphologic changes as well as the formation of
neutral lipid vacuoles were apparent as early as 1 week
after induction and visualized by staining with Sudan III
(Fig. 3a). Sudan III positivity was only observed after
application of adipogenic medium. Initially, no staining
was detectable in the stem/progenitor cell cultures. After
25 days of adipogenic induction, almost 70% of all cells
were positive for the lipid staining and eventually Wlled
with lipid vacuoles (Fig. 3a; 0 day vs. 25 days: p · 0.001).
After 1 week, adipogenic induction of tracheotomy-
derived stem/progenitor cells resulted in lineage-speciWc
gene expression and increase of marker molecules such as
the nuclear receptor peroxisome proliferation-activated
receptor  (PPAR), the fatty acid-binding protein (FABP)
aP2 and the CCAAT enhancer-binding protein alpha (C/
EBPalpha)—molecules controlling adipocyte diVerentia-
tion and function (Fig. 3b; 0 day vs. 25 days: p · 0.05).
Osteogenic diVerentiation
To assess the osteogenic diVerentiation, the stem/progenitor
cells were induced by dexamethasone, glycerol phosphate
and ascorbic acid in the presence of 10% FCS. As early as
1 week after induction, aggregates of cells showed expres-
sion of alkaline phosphatase (AP) which increased during
the ongoing diVerentiation, resulting in almost 100% AP-
positive cells on day 25 (Fig. 4b; 0 day vs. 25 days:
p · 0.001). Immunostaining revealed the expression of the
osteogenic marker molecules osteopontin and bone sialo-
protein (Fig. 4b). Both molecules could be detected after
9 days of osteogenic diVerentiation and the number of posi-
tive cells increased during further cultivation, indicating
osteogenic diVerentiation. Before application of the osteo-
genic medium, no protein expression of bone sialoprotein
was observed in the undiVerentiated cell cultures by immu-
nostaining, whereas a basal expression of osteopontin could
be detected (data not shown).
These results were conWrmed at the gene expression
level by RT-PCR analysis (Fig. 4c). Osteopontin was
already expressed in undiVerentiated cell cultures, as it has
Fig. 1 Hematoxylin-eosin (HE) staining of proliferating adipose tis-
sue-derived cells from the neck (passage 4) isolated by plastic adher-
ence after tracheotomy demonstrates a spindle-shaped morphology (a).
The cells stained positive for STRO-1 (b) and showed a stable daily
doubling index of 2.02 during further passages (c). Nuclei are stained
blue using DAPI123
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osteocalcin demonstrated an increasing expression after
9 days of osteogenic diVerentiation and continued to be
expressed at a high level until the end of the cultivation
period, indicating formation of osteoblasts.
Chondrogenic diVerentiation
To promote chondrogenic diVerentiation, we gently centri-
fuged the isolated cells to form a pelleted micromass, and
cultured the micromass bodies (MMB) in a medium con-
taining TGF-3. DiVerentiation of tracheotomy-derived
stem/progenitor cells along the chondrogenic lineage, using
the classical MMB protocol, was characterized by Alcian
blue-staining (Figure 5 a; 0 day vs. 25 days: p · 0.001). All
MMBs cultured in chondrogenic medium stained positive
for Alcian blue after 18 days of cultivation demonstrating a
proteoglycan-rich extracellular matrix. Immunostaining
revealed the expression of collagen type II, the major com-
ponent of hyaline cartilage (Fig. 5b). Collagen Type X,
which is expressed by hypertrophic chondrocytes, was
detected at the end of the 25-day diVerentiation period.
Before application of chondrogenic medium, no protein
expression of the analyzed chondrogenic marker molecules
could be found in the undiVerentiated cell cultures by
immunostaining (data not shown).
RT-PCR analysis conWrmed chondrogenic diVerentiation
and expression of collagen type II and demonstrated the
expression of aggrecan, the major proteoglycan of cartilage
tissue (Fig. 5c). Taken together, these results demonstrate
that all analyzed tracheotomy-derived stem/progenitor cells
were able to diVerentiate along the chondrogenic lineage.
Fig. 2 A representative Xow 
cytometric analysis of adipose 
tissue-derived cells from the 
neck at the 4th passage is shown. 
Isotype-matched human anti-
body control staining is depicted 
in white. The speciWc markers 
are shown in gray123
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Cells used in tissue engineering can be derived from
numerous sources, including primary tissues, cell lines and
stem cells. Stem/progenitor cells contribute to the homeo-
stasis and regeneration of tissue after trauma and disease
[23, 24]. Many sources of adult stem cells have been char-
acterized, posting the hypothesis that stem cells capable of
multilineage diVerentiation might reside in any post natal-
organ [12]. Among them, bone marrow MSC have been
found to diVerentiate along multiple mesenchymal lineages
[9–11] and have currently been used for the clinical trans-
plantation of a tissue-engineered airway [8, 25]. However,
it is necessary to obtain these cells by general anesthetic
procedures, bone marrow biopsies or even operations.
These methods may complicate the routine clinical sce-
nario.
Ideally, cells used for clinical transplantation should be
(1) easy to harvest, (2) highly proliferative, (3) autologous
and non-immunogenic and (4) able to diVerentiate into a
variety of cell types with specialized functions [26]. Most
patients undergoing extensive airway or head and neck sur-
gery require open tracheotomy to secure airway passage
until recovery of swallowing and respiratory function is
reached. In this study we investigated if stem/progenitor
cells applicable for tissue engineering of the airway func-
tion could be easily isolated from adipose tissue of the neck
during an open tracheotomy.
Characteristics that deWne mesenchymal stem/progenitor
cells include high proliferative potential, ability to generate
primary colony-forming unit-Wbroblast and the ability to
diVerentiate into bone, fat and cartilage. The multilineage
potential of adult stem cells, however, has often been con-
sidered an attribute of heterogenic cell isolates [27, 28].
Therefore, minimal criteria have been denominated to
deWne human MSC [11]. First, the cells are plastic adherent
and second, they express the CD marker molecules CD105
(endoglin), CD73 (5-nucleotidase) as well as CD90 (Thy1)
and do not express the leukocyte marker molecule CD45
and the marker molecule CD34 for primitive hematopoietic
progenitor cells. However, current studies demonstrated
that MSC cannot be distinguished from Wbroblasts by Xow
cytometric analysis using a panel of common marker mole-
cules [29]. Furthermore, various markers that are used to
purify MSC from marrow aspirates are rapidly down regu-
lated following ex vivo expansion [30] or have been attrib-
uted to diVerent subpopulations [31]. Therefore, the third
criterion plays a pivotal role: MSC must show the multilin-
eage capacity to diVerentiate into adipogenic, osteogenic
and chondrogenic cells.
In this study we were able to demonstrate that proliferat-
ing cells could be easily isolated from adipose tissue sur-
rounding the trachea by adherence to plastic culture dishes.
The isolated cells showed a spindle-shaped morphology
and expressed CD marker molecules characteristic for
MSC [11, 30] and adipose tissue-derived stem cells [32].
Fig. 3 Adipogenic diVerentia-
tion of human adipose-tissue de-
rived stem/progenitor cells from 
the neck during monolayer culti-
vation. Sudan III staining dem-
onstrates adipogenic 
diVerentiation with a maximum 
on day 25 after induction of 
diVerentiation (a). Analysis of 
relative marker gene expression 
conWrmed adipogenic diVerenti-
ation of the stem/progenitor cells 
(b). Mean values § SEM de-
rived from three independent 
experiments (n = 3) are shown. 
Bar = 100 m. *p · 0.05, 
***p · 0.001123
2568 Eur Arch Otorhinolaryngol (2012) 269:2561–2570Moreover, these cells were capable of diVerentiating
eYciently into adipogenic, osteogenic and chondrogenic
cell types under speciWc culture conditions in vitro. In addi-
tion, it has been shown that multipotential adipose tissue-
derived stem cells accelerated neovascularization and epi-
thelialization in an animal model of a tissue-engineered tra-
chea [13]. Recently, there has also been evidence that
Wbroblasts, closely related to MSC populations [33, 34]
enhanced epithelial diVerentiation and proliferation in an
applied tracheal prosthesis [35].
Conclusion
This study was able to verify the hypothesis that stem/pro-
genitor cells can be easily isolated from adipose tissue of the
neck during tracheotomy. The stem/progenitor cell isolates
showed characteristics of multipotent adult stem cells, simi-
lar to those of bone marrow-derived MSC, and given the
appropriate culture conditions demonstrated multilineage
diVerentiation into adipogenic, osteogenic and chondrogenic
cells. Furthermore, there is strong evidence that these adipose
tissue-derived stem cells from the neck meet the require-
ments for MSC [11]. Thus, additional operative interventions
to obtain bone marrow MSC through multiple time-intensive
general anesthetic procedures, biopsies and operations may
no longer be necessary to receive MSC-derived tissue-engi-
neered airway transplantation. Direct sources of autologous,
highly proliferative, multipotent stem cells for clinical trans-
plantation which can be safely extracted during a one-time
procedure will be pivotal for regenerative medicine in the
future. To safely apply stem/progenitor cells in future medi-
cine it will also be necessary to understand the integration
and interaction of these cells with surrounding cellular struc-
tures [36]. The goal of future studies is to optimize the diVer-
entiation and application of adipose tissue-derived stem/
progenitor cells from the neck for the reconstructive surgery
of tracheal or bronchial airway.
Fig. 4 Osteogenic diVerentia-
tion of human adipose-tissue de-
rived stem/progenitor cells from 
the neck during monolayer culti-
vation. Alkaline phosphatase 
(AP) staining demonstrates oste-
ogenic diVerentiation with a 
maximum on day 25 after induc-
tion of diVerentiation (a). 
Expression of osteopontin (OP) 
and bone sialoprotein (BSP) is 
shown by immunostaining. Nu-
clei are stained blue using DAPI 
(b). Analysis of relative marker 
gene expression conWrmed oste-
ogenic diVerentiation of the 
stem/progenitor cells (c). Mean 
values § SEM derived from 
three independent experiments 
(n = 3) are shown. 
Bar = 100 m. ***p · 0.001123
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